1. Home
  2. DBVT vs LTRX Comparison

DBVT vs LTRX Comparison

Compare DBVT & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • LTRX
  • Stock Information
  • Founded
  • DBVT 2002
  • LTRX 1989
  • Country
  • DBVT France
  • LTRX United States
  • Employees
  • DBVT N/A
  • LTRX N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • LTRX Computer Communications Equipment
  • Sector
  • DBVT Health Care
  • LTRX Telecommunications
  • Exchange
  • DBVT Nasdaq
  • LTRX Nasdaq
  • Market Cap
  • DBVT 102.0M
  • LTRX 112.3M
  • IPO Year
  • DBVT N/A
  • LTRX 2000
  • Fundamental
  • Price
  • DBVT $4.47
  • LTRX $3.51
  • Analyst Decision
  • DBVT Strong Buy
  • LTRX Strong Buy
  • Analyst Count
  • DBVT 2
  • LTRX 5
  • Target Price
  • DBVT $22.50
  • LTRX $6.50
  • AVG Volume (30 Days)
  • DBVT 141.9K
  • LTRX 388.4K
  • Earning Date
  • DBVT 03-06-2025
  • LTRX 02-06-2025
  • Dividend Yield
  • DBVT N/A
  • LTRX N/A
  • EPS Growth
  • DBVT N/A
  • LTRX N/A
  • EPS
  • DBVT N/A
  • LTRX N/A
  • Revenue
  • DBVT $12,515,000.00
  • LTRX $161,719,000.00
  • Revenue This Year
  • DBVT N/A
  • LTRX N/A
  • Revenue Next Year
  • DBVT $2,860.00
  • LTRX $11.70
  • P/E Ratio
  • DBVT N/A
  • LTRX N/A
  • Revenue Growth
  • DBVT 125.54
  • LTRX 22.12
  • 52 Week Low
  • DBVT $0.44
  • LTRX $2.49
  • 52 Week High
  • DBVT $5.42
  • LTRX $6.90
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 61.49
  • LTRX 43.83
  • Support Level
  • DBVT $4.30
  • LTRX $3.38
  • Resistance Level
  • DBVT $5.15
  • LTRX $4.49
  • Average True Range (ATR)
  • DBVT 0.41
  • LTRX 0.26
  • MACD
  • DBVT 0.06
  • LTRX -0.09
  • Stochastic Oscillator
  • DBVT 60.70
  • LTRX 11.71

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

About LTRX Lantronix Inc.

Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.

Share on Social Networks: